Table 1.
Demographic characteristics and medication use
| Total (325) | pRBD (141) | Non-RBD (184) | p value | |
|---|---|---|---|---|
| Male:female | 213:112 (65.5) | 106:35 (75.2) | 107:77 (58.2) | < 0.01 |
| Age, years | 64.9 (9.4) | 64.1 (9.4) | 65.4 (9.4) | 0.45 |
| Disease duration, years | 9.2 (6.9) | 10.9 (7.2) | 7.7 (6.4) | 0.02 |
| Levodopa yes:no | 270:53 (83.6) | 124:15 (87.9) | 146:38 (79.3) | 0.50 |
| Agonist yes:no | 213:110 (65.9) | 80:59 (56.7) | 133:51 (72.3) | 0.03 |
| SSRI/SNRI yes:no | 52:269 (16.2) | 32:106 (22.7) | 20:163 (10.9) | 0.02 |
| Benzodiazepine yes:no | 42:278 (15.1) | 22:115 (15.6) | 20:163 (10.9) | 0.20 |
| Clonazepam yes:no | 19:302 (5.8) | 12:126 (8.5) | 7:176 (3.8) | 0.50 |
Demographic data and medication use in PD patients with and without pRBD, respectively. Numbers in parentheses refers to percentage, except for age and disease duration, where it refers to standard deviation. P values refer to binary logistic regression analyses
Abbreviations: pRBD possible REM-sleep behavior disorder, SSRI selective serotonin reuptake inhibitor, SNRI serotonin and norepinephrine reuptake inhibitor